Abstract
Sterile perforated polyethylene spheres (wiffle golf balls) were implanted s.c. in beagle dogs. A local inflammatory reaction was elicited within the spheres by injecting carrageenan. Changes in leukocyte count, prostaglandin E2, thromboxane B2 and leukotriene B4levels were monitored in fluid samples collected over a 24-hr period. Blood samples were also collected at various time points and analyzed for prostaglandin E2 and leukotriene B4 production after ex vivo calcium ionophore treatment. Effects of standard antiinflammatory agents (aspirin, indomethacin, dexamethasone, tenidap and zileuton) and newer cyclooxygenase-2 (COX-2) selective agents (nimesulide, nabumetone and SC-58125) were determined after oral administration. Ex vivoinhibition of cyclooxygenase product synthesis (prostaglandin E2, thromboxane B2) in whole blood was used as an indicator of activity for the constitutive COX-1 isoform, although inhibition of the synthesis of these mediators in the chamber exudate during an inflammatory process is believed to represent COX-2 inhibition. Treatment effects on leukotriene B4 production were also determined both ex vivo in whole blood and in the fluid. All of the compounds tested, except aspirin, inhibited leukocyte infiltration into the fluid exudate. Inhibitors that exert their effects on both isozymes of cyclooxygenase attenuate production of cyclooxygenase metabolites in both the inflammatory exudate and in peripheral blood ex vivo, although COX-2 selective inhibitors only demonstrated activity in the exudate. A 5-lipoxygenase inhibitor (zileuton), a corticosteroid (dexamethasone) and a dual COX-2 selective/5-lipoxygenase inhibitor (RWJ 63556) had similar profiles in that they all inhibited cell infiltration and eicosanoid production in the fluid and also attenuated leukotriene B4production in both the fluid and blood.
Footnotes
-
Send reprint requests to: Thomas Kirchner, Department of Inflammation Research, The R.W. Johnson Pharmaceutical Research Institute, Route 202, Raritan, NJ 08869.
- Abbreviations:
- COX
- cyclooxygenase
- PGE2
- prostaglandin E2
- TxB2
- thromboxane B2
- LTB4
- leukotrine B4
- COX-1
- cyclooxygenase-1
- COX-2
- cyclooxygenase-2
- 5-LO
- 5-lipoxygenase
- RBL-1
- rat basophilic leukemia cells
- PGD2
- prostaglandin D2
- 5-HETE
- 5-hydroxy eicosatetraenoic acid
- RIA
- radioimmunoassay
- ELISA
- enzyme linked immunosorbant assay
- PAGE
- polyacrylamide gel electrophoresis
- SC-58125
- ORTHO-{[4-(4-aminophenyl)sufonyl}phenylaminocarbonyl} benzoic acid
- RWJ 63556
- N-[5-(4-fluorophenoxy)thien-2-yl]methane sulfonamide: GI, gastrointestinal: NSAIDs, nonsteroidal antiinflammatory drugs
- Received January 10, 1997.
- Accepted April 4, 1997.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|